NCT03393338: DM I-TEAM

Diabetes Interprofessional Team to Enhance Adherence to Medical Care

Completed NA Last updated 19 October 2022

What this trial tests

NA trial testing DM I-TEAM in Diabetes in 200 participants. Completed in 31 December 2021.

Timeline

1 January 2017

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Thomas Jefferson University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	200
Start date	1 January 2017
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across United States

Drugs / interventions tested

• DM I-TEAM

Conditions studied

• Diabetes — all drugs for Diabetes →

Sponsor

Thomas Jefferson University

Who can join

35 and older, any sex, with Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goal of this randomized controlled trial is to test the efficacy of DM I-TEAM (Diabetes Interprofessional Team to Enhance Adherence to Medical Care) to reduce emergency department (ED) visits and hospitalizations over 12 months in older African Americans (AAs) with diabetes mellitus (DM). DM I-TEAM is a multidisciplinary behavioral intervention that comprises a community health worker (CHW), the participant's primary care physician (PCP), a diabetes nurse educator, and a clinical geriatric pharmacist. In DM I-TEAM, the CHW conducts in-home sessions to: (1) provide diabetes education, (2) facilitate adherence to diabetes self-management behaviors (e.g., medication adherence glucose monitoring, diet, exercise); and (3) build trust between patients and their primary care team. This is accomplished by: (1) using culturally relevant diabetes educational materials; (2) facilitating telehealth visits with the participant's PCP and the diabetes nurse educator via JeffConnect; and (3) having the study pharmacist review participants' medication regimens to identify potentially inappropriate medications, simplify medication regimens if possible, and to reduce medication side effects.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

1. Mistrust, Neighborhood Deprivation, and Telehealth Use in African Americans with Diabetes.
   Rovner BW, Casten RJ, Chang AM, Hollander JE, et al · · 2021 · cited 19× · PMID 34000211 · DOI 10.1089/pop.2021.0094
2. Emergency department visits in African Americans with mild cognitive impairment and diabetes.
   Rovner BW, Casten RJ. · · 2021 · cited 5× · PMID 33752964 · DOI 10.1016/j.jdiacomp.2021.107905
3. Interprofessional Intervention to Reduce Emergency Department Visits in Black Individuals with Diabetes.
   Rovner BW, Casten R, Chang AM, Hollander JE, et al · · 2023 · cited 4× · PMID 36745390 · DOI 10.1089/pop.2022.0216
4. Emergency Department Use in Black Individuals With Diabetes.
   Rovner B, Casten R, Nightingale G, Leiby BE, et al · · 2023 · PMID 37982058 · DOI 10.2337/ds22-0091